Table of Content

1 Report Overview
1.1 NK Cells Definition
1.2 Market by Type
1.2.1 Global NK Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global NK Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global NK Cells Sales
2.1 Global NK Cells Revenue Estimates and Forecasts 2018-2034
2.2 Global NK Cells Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global NK Cells Revenue by Region
2.3.1 Global NK Cells Revenue by Region (2018-2024)
2.3.2 Global NK Cells Revenue by Region (2024-2034)
2.4 Global NK Cells Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global NK Cells Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global NK Cells Sales Quantity by Region
2.6.1 Global NK Cells Sales Quantity by Region (2018-2024)
2.6.2 Global NK Cells Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global NK Cells Sales Quantity by Manufacturers
3.1.1 Global NK Cells Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global NK Cells Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by NK Cells Sales in 2022
3.2 Global NK Cells Revenue by Manufacturers
3.2.1 Global NK Cells Revenue by Manufacturers (2018-2024)
3.2.2 Global NK Cells Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by NK Cells Revenue in 2022
3.3 Global NK Cells Sales Price by Manufacturers
3.4 Global Key Players of NK Cells, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of NK Cells, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of NK Cells, Product Offered and Application
3.8 Global Key Manufacturers of NK Cells, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global NK Cells Sales Quantity by Type
4.1.1 Global NK Cells Historical Sales Quantity by Type (2018-2024)
4.1.2 Global NK Cells Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global NK Cells Sales Quantity Market Share by Type (2018-2034)
4.2 Global NK Cells Revenue by Type
4.2.1 Global NK Cells Historical Revenue by Type (2018-2024)
4.2.2 Global NK Cells Forecasted Revenue by Type (2024-2034)
4.2.3 Global NK Cells Revenue Market Share by Type (2018-2034)
4.3 Global NK Cells Price by Type
4.3.1 Global NK Cells Price by Type (2018-2024)
4.3.2 Global NK Cells Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global NK Cells Sales Quantity by Application
5.1.1 Global NK Cells Historical Sales Quantity by Application (2018-2024)
5.1.2 Global NK Cells Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global NK Cells Sales Quantity Market Share by Application (2018-2034)
5.2 Global NK Cells Revenue by Application
5.2.1 Global NK Cells Historical Revenue by Application (2018-2024)
5.2.2 Global NK Cells Forecasted Revenue by Application (2024-2034)
5.2.3 Global NK Cells Revenue Market Share by Application (2018-2034)
5.3 Global NK Cells Price by Application
5.3.1 Global NK Cells Price by Application (2018-2024)
5.3.2 Global NK Cells Price Forecast by Application (2024-2034)
6 North America
6.1 North America NK Cells Sales by Company
6.1.1 North America NK Cells Revenue by Company (2018-2024)
6.1.2 North America NK Cells Sales Quantity by Company (2018-2024)
6.2 North America NK Cells Market Size by Type
6.2.1 North America NK Cells Sales Quantity by Type (2018-2034)
6.2.2 North America NK Cells Revenue by Type (2018-2034)
6.3 North America NK Cells Market Size by Application
6.3.1 North America NK Cells Sales Quantity by Application (2018-2034)
6.3.2 North America NK Cells Revenue by Application (2018-2034)
6.4 North America NK Cells Market Size by Country
6.4.1 North America NK Cells Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America NK Cells Revenue by Country (2018-2034)
6.4.3 North America NK Cells Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe NK Cells Sales by Company
7.1.1 Europe NK Cells Sales Quantity by Company (2018-2024)
7.1.2 Europe NK Cells Revenue by Company (2018-2024)
7.2 Europe NK Cells Market Size by Type
7.2.1 Europe NK Cells Sales Quantity by Type (2018-2034)
7.2.2 Europe NK Cells Revenue by Type (2018-2034)
7.3 Europe NK Cells Market Size by Application
7.3.1 Europe NK Cells Sales Quantity by Application (2018-2034)
7.3.2 Europe NK Cells Revenue by Application (2018-2034)
7.4 Europe NK Cells Market Size by Country
7.4.1 Europe NK Cells Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe NK Cells Revenue by Country (2018-2034)
7.4.3 Europe NK Cells Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China NK Cells Sales by Company
8.1.1 China NK Cells Sales Quantity by Company (2018-2024)
8.1.2 China NK Cells Revenue by Company (2018-2024)
8.2 China NK Cells Market Size by Type
8.2.1 China NK Cells Sales Quantity by Type (2018-2034)
8.2.2 China NK Cells Revenue by Type (2018-2034)
8.3 China NK Cells Market Size by Application
8.3.1 China NK Cells Sales Quantity by Application (2018-2034)
8.3.2 China NK Cells Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC NK Cells Sales by Company
9.1.1 APAC NK Cells Sales Quantity by Company (2018-2024)
9.1.2 APAC NK Cells Revenue by Company (2018-2024)
9.2 APAC NK Cells Market Size by Type
9.2.1 APAC NK Cells Sales Quantity by Type (2018-2034)
9.2.2 APAC NK Cells Revenue by Type (2018-2034)
9.3 APAC NK Cells Market Size by Application
9.3.1 APAC NK Cells Sales Quantity by Application (2018-2034)
9.3.2 APAC NK Cells Revenue by Application (2018-2034)
9.4 APAC NK Cells Market Size by Region
9.4.1 APAC NK Cells Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC NK Cells Revenue by Region (2018-2034)
9.4.3 APAC NK Cells Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America NK Cells Sales by Company
10.1.1 Middle East, Africa and Latin America NK Cells Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America NK Cells Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America NK Cells Market Size by Type
10.2.1 Middle East, Africa and Latin America NK Cells Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America NK Cells Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America NK Cells Market Size by Application
10.3.1 Middle East, Africa and Latin America NK Cells Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America NK Cells Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America NK Cells Market Size by Country
10.4.1 Middle East, Africa and Latin America NK Cells Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America NK Cells Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America NK Cells Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Information
11.1.2 Chipscreen Biosciences Overview
11.1.3 Chipscreen Biosciences NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Chipscreen Biosciences NK Cells Products and Services
11.1.5 Chipscreen Biosciences NK Cells SWOT Analysis
11.1.6 Chipscreen Biosciences Recent Developments
11.2 Affimed NV
11.2.1 Affimed NV Company Information
11.2.2 Affimed NV Overview
11.2.3 Affimed NV NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Affimed NV NK Cells Products and Services
11.2.5 Affimed NV NK Cells SWOT Analysis
11.2.6 Affimed NV Recent Developments
11.3 Altor BioScience
11.3.1 Altor BioScience Company Information
11.3.2 Altor BioScience Overview
11.3.3 Altor BioScience NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Altor BioScience NK Cells Products and Services
11.3.5 Altor BioScience NK Cells SWOT Analysis
11.3.6 Altor BioScience Recent Developments
11.4 Innate Pharma
11.4.1 Innate Pharma Company Information
11.4.2 Innate Pharma Overview
11.4.3 Innate Pharma NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Innate Pharma NK Cells Products and Services
11.4.5 Innate Pharma NK Cells SWOT Analysis
11.4.6 Innate Pharma Recent Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Overview
11.5.3 Takeda NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Takeda NK Cells Products and Services
11.5.5 Takeda NK Cells SWOT Analysis
11.5.6 Takeda Recent Developments
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Information
11.6.2 Sorrento Therapeutics Overview
11.6.3 Sorrento Therapeutics NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Sorrento Therapeutics NK Cells Products and Services
11.6.5 Sorrento Therapeutics NK Cells SWOT Analysis
11.6.6 Sorrento Therapeutics Recent Developments
11.7 NantKwest
11.7.1 NantKwest Company Information
11.7.2 NantKwest Overview
11.7.3 NantKwest NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 NantKwest NK Cells Products and Services
11.7.5 NantKwest NK Cells SWOT Analysis
11.7.6 NantKwest Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Overview
11.8.3 Bristol-Myers Squibb NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Bristol-Myers Squibb NK Cells Products and Services
11.8.5 Bristol-Myers Squibb NK Cells SWOT Analysis
11.8.6 Bristol-Myers Squibb Recent Developments
11.9 NKT
11.9.1 NKT Company Information
11.9.2 NKT Overview
11.9.3 NKT NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 NKT NK Cells Products and Services
11.9.5 NKT NK Cells SWOT Analysis
11.9.6 NKT Recent Developments
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Information
11.10.2 Henry Ford Health Services Overview
11.10.3 Henry Ford Health Services NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Henry Ford Health Services NK Cells Products and Services
11.10.5 Henry Ford Health Services NK Cells SWOT Analysis
11.10.6 Henry Ford Health Services Recent Developments
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Information
11.11.2 Fortress Biotech Overview
11.11.3 Fortress Biotech NK Cells Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Fortress Biotech NK Cells Products and Services
11.11.5 Fortress Biotech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 NK Cells Value Chain Analysis
12.2 NK Cells Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 NK Cells Production Mode & Process
12.4 NK Cells Sales and Marketing
12.4.1 NK Cells Sales Channels
12.4.2 NK Cells Distributors
12.5 NK Cells Customers
13 Market Dynamics
13.1 NK Cells Industry Trends
13.2 NK Cells Market Drivers
13.3 NK Cells Market Challenges
13.4 NK Cells Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global NK Cells Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Mogamulizumab
Table 3. Major Manufacturers of Lorvotuzumab Mertansine
Table 4. Major Manufacturers of Others
Table 5. Global NK Cells Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global NK Cells Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global NK Cells Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global NK Cells Revenue Market Share by Region (2018-2024)
Table 9. Global NK Cells Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global NK Cells Revenue Market Share by Region (2024-2034)
Table 11. Global NK Cells Sales Quantity by Region: 2018 VS 2022 VS 2034 (g)
Table 12. Global NK Cells Sales by Region (2018-2024) & (g)
Table 13. Global NK Cells Sales Market Share by Region (2018-2024)
Table 14. Global NK Cells Sales by Region (2024-2034) & (g)
Table 15. Global NK Cells Sales Market Share by Region (2024-2034)
Table 16. Global NK Cells Sales Quantity by Manufacturers (2018-2024) & (g)
Table 17. Global NK Cells Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global NK Cells Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global NK Cells Revenue Share by Manufacturers (2018-2024)
Table 20. Global NK Cells Price by Manufacturers 2018-2024 (USD/g)
Table 21. Global Key Players of NK Cells, Industry Ranking, 2021 VS 2022
Table 22. Global NK Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global NK Cells by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NK Cells as of 2022)
Table 24. Global Key Manufacturers of NK Cells, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of NK Cells, Product Offered and Application
Table 26. Global Key Manufacturers of NK Cells, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global NK Cells Sales Quantity by Type (2018-2024) & (g)
Table 29. Global NK Cells Sales Quantity by Type (2024-2034) & (g)
Table 30. Global NK Cells Sales Quantity Share by Type (2018-2024)
Table 31. Global NK Cells Sales Quantity Share by Type (2024-2034)
Table 32. Global NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global NK Cells Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global NK Cells Revenue Share by Type (2018-2024)
Table 35. Global NK Cells Revenue Share by Type (2024-2034)
Table 36. NK Cells Price by Type (2018-2024) & (USD/g)
Table 37. Global NK Cells Price Forecast by Type (2024-2034) & (USD/g)
Table 38. Global NK Cells Sales Quantity by Application (2018-2024) & (g)
Table 39. Global NK Cells Sales Quantity by Application (2024-2034) & (g)
Table 40. Global NK Cells Sales Quantity Share by Application (2018-2024)
Table 41. Global NK Cells Sales Quantity Share by Application (2024-2034)
Table 42. Global NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global NK Cells Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global NK Cells Revenue Share by Application (2018-2024)
Table 45. Global NK Cells Revenue Share by Application (2024-2034)
Table 46. NK Cells Price by Application (2018-2024) & (USD/g)
Table 47. Global NK Cells Price Forecast by Application (2024-2034) & (USD/g)
Table 48. North America NK Cells Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America NK Cells Sales Quantity by Company (2018-2024) & (g)
Table 50. North America NK Cells Sales Quantity by Type (2018-2024) & (g)
Table 51. North America NK Cells Sales Quantity by Type (2024-2034) & (g)
Table 52. North America NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America NK Cells Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America NK Cells Sales Quantity by Application (2018-2024) & (g)
Table 55. North America NK Cells Sales Quantity by Application (2024-2034) & (g)
Table 56. North America NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America NK Cells Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America NK Cells Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America NK Cells Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America NK Cells Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America NK Cells Sales Quantity by Country (2018-2024) & (g)
Table 62. North America NK Cells Sales Quantity by Country (2024-2034) & (g)
Table 63. Europe NK Cells Sales Quantity by Company (2018-2024) & (g)
Table 64. Europe NK Cells Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe NK Cells Sales Quantity by Type (2018-2024) & (g)
Table 66. Europe NK Cells Sales Quantity by Type (2024-2034) & (g)
Table 67. Europe NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe NK Cells Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe NK Cells Sales Quantity by Application (2018-2024) & (g)
Table 70. Europe NK Cells Sales Quantity by Application (2024-2034) & (g)
Table 71. Europe NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe NK Cells Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe NK Cells Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe NK Cells Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe NK Cells Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe NK Cells Sales Quantity by Country (2018-2024) & (g)
Table 77. Europe NK Cells Sales Quantity by Country (2024-2034) & (g)
Table 78. China NK Cells Sales Quantity by Company (2018-2024) & (g)
Table 79. China NK Cells Revenue by Company (2018-2024) & (US$ Million)
Table 80. China NK Cells Sales Quantity by Type (2018-2024) & (g)
Table 81. China NK Cells Sales Quantity by Type (2024-2034) & (g)
Table 82. China NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 83. China NK Cells Revenue by Type (2024-2034) & (US$ Million)
Table 84. China NK Cells Sales Quantity by Application (2018-2024) & (g)
Table 85. China NK Cells Sales Quantity by Application (2024-2034) & (g)
Table 86. China NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 87. China NK Cells Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC NK Cells Sales Quantity by Company (2018-2024) & (g)
Table 89. APAC NK Cells Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC NK Cells Sales Quantity by Type (2018-2024) & (g)
Table 91. APAC NK Cells Sales Quantity by Type (2024-2034) & (g)
Table 92. APAC NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC NK Cells Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC NK Cells Sales Quantity by Application (2018-2024) & (g)
Table 95. APAC NK Cells Sales Quantity by Application (2024-2034) & (g)
Table 96. APAC NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC NK Cells Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC NK Cells Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC NK Cells Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC NK Cells Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC NK Cells Sales Quantity by Region (2018-2024) & (g)
Table 102. APAC NK Cells Sales Quantity by Region (2024-2034) & (g)
Table 103. Middle East, Africa and Latin America NK Cells Sales Quantity by Company (2018-2024) & (g)
Table 104. Middle East, Africa and Latin America NK Cells Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America NK Cells Sales Quantity by Type (2018-2024) & (g)
Table 106. Middle East, Africa and Latin America NK Cells Sales Quantity by Type (2024-2034) & (g)
Table 107. Middle East, Africa and Latin America NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America NK Cells Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America NK Cells Sales Quantity by Application (2018-2024) & (g)
Table 110. Middle East, Africa and Latin America NK Cells Sales Quantity by Application (2024-2034) & (g)
Table 111. Middle East, Africa and Latin America NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America NK Cells Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America NK Cells Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America NK Cells Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America NK Cells Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America NK Cells Sales Quantity by Country (2018-2024) & (g)
Table 117. Middle East, Africa and Latin America NK Cells Sales Quantity by Country (2024-2034) & (g)
Table 118. Chipscreen Biosciences Company Information
Table 119. Chipscreen Biosciences Description and Overview
Table 120. Chipscreen Biosciences NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 121. Chipscreen Biosciences NK Cells Product and Services
Table 122. Chipscreen Biosciences NK Cells SWOT Analysis
Table 123. Chipscreen Biosciences Recent Developments
Table 124. Affimed NV Company Information
Table 125. Affimed NV Description and Overview
Table 126. Affimed NV NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 127. Affimed NV NK Cells Product and Services
Table 128. Affimed NV NK Cells SWOT Analysis
Table 129. Affimed NV Recent Developments
Table 130. Altor BioScience Company Information
Table 131. Altor BioScience Description and Overview
Table 132. Altor BioScience NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 133. Altor BioScience NK Cells Product and Services
Table 134. Altor BioScience NK Cells SWOT Analysis
Table 135. Altor BioScience Recent Developments
Table 136. Innate Pharma Company Information
Table 137. Innate Pharma Description and Overview
Table 138. Innate Pharma NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 139. Innate Pharma NK Cells Product and Services
Table 140. Innate Pharma NK Cells SWOT Analysis
Table 141. Innate Pharma Recent Developments
Table 142. Takeda Company Information
Table 143. Takeda Description and Overview
Table 144. Takeda NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 145. Takeda NK Cells Product and Services
Table 146. Takeda NK Cells SWOT Analysis
Table 147. Takeda Recent Developments
Table 148. Sorrento Therapeutics Company Information
Table 149. Sorrento Therapeutics Description and Overview
Table 150. Sorrento Therapeutics NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 151. Sorrento Therapeutics NK Cells Product and Services
Table 152. Sorrento Therapeutics NK Cells SWOT Analysis
Table 153. Sorrento Therapeutics Recent Developments
Table 154. NantKwest Company Information
Table 155. NantKwest Description and Overview
Table 156. NantKwest NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 157. NantKwest NK Cells Product and Services
Table 158. NantKwest NK Cells SWOT Analysis
Table 159. NantKwest Recent Developments
Table 160. Bristol-Myers Squibb Company Information
Table 161. Bristol-Myers Squibb Description and Overview
Table 162. Bristol-Myers Squibb NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 163. Bristol-Myers Squibb NK Cells Product and Services
Table 164. Bristol-Myers Squibb NK Cells SWOT Analysis
Table 165. Bristol-Myers Squibb Recent Developments
Table 166. NKT Company Information
Table 167. NKT Description and Overview
Table 168. NKT NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 169. NKT NK Cells Product and Services
Table 170. NKT NK Cells SWOT Analysis
Table 171. NKT Recent Developments
Table 172. Henry Ford Health Services Company Information
Table 173. Henry Ford Health Services Description and Overview
Table 174. Henry Ford Health Services NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 175. Henry Ford Health Services NK Cells Product and Services
Table 176. Henry Ford Health Services NK Cells SWOT Analysis
Table 177. Henry Ford Health Services Recent Developments
Table 178. Fortress Biotech Company Information
Table 179. Fortress Biotech Description and Overview
Table 180. Fortress Biotech NK Cells Sales Quantity (g), Revenue (US$ Million), Average Selling Price (ASP) (USD/g) and Gross Margin (2018-2024)
Table 181. Fortress Biotech NK Cells Product and Services
Table 182. Fortress Biotech Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. NK Cells Distributors List
Table 186. NK Cells Customers List
Table 187. NK Cells Market Trends
Table 188. NK Cells Market Drivers
Table 189. NK Cells Market Challenges
Table 190. NK Cells Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. NK Cells Product Picture
Figure 2. Global NK Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global NK Cells Market Share by Type in 2022 & 2034
Figure 4. Mogamulizumab Product Picture
Figure 5. Lorvotuzumab Mertansine Product Picture
Figure 6. Others Product Picture
Figure 7. Global NK Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global NK Cells Market Share by Application in 2022 & 2034
Figure 9. Cancer
Figure 10. Cardiovascular Diseases
Figure 11. Others
Figure 12. NK Cells Report Years Considered
Figure 13. Global NK Cells Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global NK Cells Revenue 2018-2034 (US$ Million)
Figure 15. Global NK Cells Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global NK Cells Sales Quantity 2018-2034 (g)
Figure 17. Global NK Cells Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global NK Cells Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America NK Cells Sales Quantity YoY (2018-2034) & (g)
Figure 20. North America NK Cells Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe NK Cells Sales Quantity YoY (2018-2034) & (g)
Figure 22. Europe NK Cells Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China NK Cells Sales Quantity YoY (2018-2034) & (g)
Figure 24. China NK Cells Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC NK Cells Sales Quantity YoY (2018-2034) & (g)
Figure 26. APAC NK Cells Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America NK Cells Sales Quantity YoY (2018-2034) & (g)
Figure 28. Middle East, Africa and Latin America NK Cells Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by NK Cells Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by NK Cells Revenue in 2022
Figure 31. NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global NK Cells Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global NK Cells Revenue Market Share by Type (2018-2034)
Figure 34. Global NK Cells Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global NK Cells Revenue Market Share by Application (2018-2034)
Figure 36. North America NK Cells Revenue Market Share by Company in 2022
Figure 37. North America NK Cells Sales Quantity Market Share by Company in 2022
Figure 38. North America NK Cells Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America NK Cells Revenue Market Share by Type (2018-2034)
Figure 40. North America NK Cells Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America NK Cells Revenue Market Share by Application (2018-2034)
Figure 42. North America NK Cells Revenue Share by Country (2018-2034)
Figure 43. North America NK Cells Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. NK Cells Revenue (2018-2034) & (US$ Million)
Figure 45. Canada NK Cells Revenue (2018-2034) & (US$ Million)
Figure 46. Europe NK Cells Sales Quantity Market Share by Company in 2022
Figure 47. Europe NK Cells Revenue Market Share by Company in 2022
Figure 48. Europe NK Cells Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe NK Cells Revenue Market Share by Type (2018-2034)
Figure 50. Europe NK Cells Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe NK Cells Revenue Market Share by Application (2018-2034)
Figure 52. Europe NK Cells Revenue Share by Country (2018-2034)
Figure 53. Europe NK Cells Sales Quantity Share by Country (2018-2034)
Figure 54. Germany NK Cells Revenue (2018-2034) & (US$ Million)
Figure 55. France NK Cells Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. NK Cells Revenue (2018-2034) & (US$ Million)
Figure 57. Italy NK Cells Revenue (2018-2034) & (US$ Million)
Figure 58. Russia NK Cells Revenue (2018-2034) & (US$ Million)
Figure 59. China NK Cells Sales Quantity Market Share by Company in 2022
Figure 60. China NK Cells Revenue Market Share by Company in 2022
Figure 61. China NK Cells Sales Quantity Market Share by Type (2018-2034)
Figure 62. China NK Cells Revenue Market Share by Type (2018-2034)
Figure 63. China NK Cells Sales Quantity Market Share by Application (2018-2034)
Figure 64. China NK Cells Revenue Market Share by Application (2018-2034)
Figure 65. APAC NK Cells Sales Quantity Market Share by Company in 2022
Figure 66. APAC NK Cells Revenue Market Share by Company in 2022
Figure 67. APAC NK Cells Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC NK Cells Revenue Market Share by Type (2018-2034)
Figure 69. APAC NK Cells Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC NK Cells Revenue Market Share by Application (2018-2034)
Figure 71. APAC NK Cells Revenue Share by Region (2018-2034)
Figure 72. APAC NK Cells Sales Quantity Share by Region (2018-2034)
Figure 73. Japan NK Cells Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea NK Cells Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan NK Cells Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia NK Cells Revenue (2018-2034) & (US$ Million)
Figure 77. India NK Cells Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America NK Cells Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America NK Cells Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America NK Cells Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America NK Cells Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America NK Cells Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America NK Cells Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America NK Cells Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America NK Cells Revenue Share by Country (2018-2034)
Figure 86. Brazil NK Cells Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico NK Cells Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey NK Cells Revenue (2018-2034) & (US$ Million)
Figure 89. Israel NK Cells Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries NK Cells Revenue (2018-2034) & (US$ Million)
Figure 91. NK Cells Value Chain
Figure 92. NK Cells Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed